14.SINGLE-AGENT CETUXIMAB AS FIRST-LINE TREATMENT FOR ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER. PRELIMINARY RESULTS OF A TTD PHASE II STUDY Conference Poster 2006 Congress communication